These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 224550)

  • 1. The relationship between somatostatin binding and cyclic AMP-stimulated protein kinase inhibition.
    Leitner JW; Rifkin RM; Maman A; Sussman KE
    Metabolism; 1980 Oct; 29(11):1065-74. PubMed ID: 6107815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases.
    Tachikawa E; Tank AW; Yanagihara N; Mosimann W; Weiner N
    Mol Pharmacol; 1986 Nov; 30(5):476-85. PubMed ID: 2877391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of somatostatin on the activation of adenosine 3',5'-monophosphate-dependent protein kinase in isolated rat islets of Langerhans.
    Oliver JR; Kemp BE
    Endocrinology; 1980 Apr; 106(4):1259-64. PubMed ID: 6244148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic adenosine 3',5'monophosphate/protein kinase A and mitogen-activated protein kinase 3/1 pathways are involved in adenylate cyclase-activating polypeptide 1-induced common alpha-glycoprotein subunit gene (Cga) expression in mouse pituitary gonadotroph LbetaT2 cells.
    Harada T; Kanasaki H; Mutiara S; Oride A; Miyazaki K
    Biol Reprod; 2007 Oct; 77(4):707-16. PubMed ID: 17596563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective cyclic adenosine 3'-5'-monophosphate-dependent phosphorylation of plasma membrane proteins in chemically and virally transformed cells.
    Scott RE; Dousa TP
    Cancer Res; 1980 Aug; 40(8 Pt 1):2860-8. PubMed ID: 6248215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin inhibits interleukin 6 release from rat cortical type I astrocytes via the inhibition of adenylyl cyclase.
    Grimaldi M; Florio T; Schettini G
    Biochem Biophys Res Commun; 1997 Jun; 235(1):242-8. PubMed ID: 9196070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene.
    Montminy MR; Bilezikjian LM
    Nature; 1987 Jul 9-15; 328(6126):175-8. PubMed ID: 2885756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP-dependent protein phosphorylation in the rat anterior pituitary.
    Cain ST; Pryor JC; Nemeroff CB
    Synapse; 1990; 5(3):241-6. PubMed ID: 2160742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucagon and cyclic adenosine 3',5'-monophosphate on protein phosphorylation in rat pancreatic islets.
    Suzuki S; Oka H; Yasuda H; Ikeda M; Cheng PY; Oda T
    Endocrinology; 1983 Jan; 112(1):348-52. PubMed ID: 6128226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase activities in rat pancreatic islets of Langerhans.
    Sugden MC; Ashcroft SJ; Sugden PH
    Biochem J; 1979 Apr; 180(1):219-29. PubMed ID: 226067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin inhibits fusion of pituitary secretion vesicles with the plasma membranes.
    Draznin B; Steiner C; Sherman N; Sussman K
    Biochem Biophys Res Commun; 1986 Sep; 139(2):673-8. PubMed ID: 2876705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin effects on the cyclic AMP system and lipid metabolism in mouse brain.
    Catalan RE; Martinez AM; Miguel BG; Robles A; Aragones MD
    Neurochem Res; 1986 Apr; 11(4):497-504. PubMed ID: 2873518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclic AMP-dependent protein kinase by somatostatin in slices of mouse brain: dependence on extracellular calcium.
    Catalán RE; Martínez AM; Aragonés MD
    Neuropharmacology; 1983 May; 22(5):641-5. PubMed ID: 6136008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by somatostatin of adenosine-3',5'-monophosphate stimulated hepatic ribosomal protein synthesis.
    Tragl KH; Kinast H
    Klin Wochenschr; 1977 Jul; 55(14):707-9. PubMed ID: 197300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of insulin secretagogues in the regulation of somatostatin binding by isolated rat islets.
    Mehler PS; Sussman AL; Maman A; Leitner JW; Sussman KE
    J Clin Invest; 1980 Dec; 66(6):1334-8. PubMed ID: 6108333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high doses of somatostatin on adenylate cyclase activity in peripheral mononuclear leukocytes from normal subjects and from acute leukemia patients.
    Peracchi M; Bamonti-Catena F; Bareggi B
    Experientia; 1988 Jul; 44(7):613-5. PubMed ID: 2899519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous somatostatin and the gut.
    Lucey MR
    Gut; 1986 Apr; 27(4):457-67. PubMed ID: 2870009
    [No Abstract]   [Full Text] [Related]  

  • 19. Somatostatin: selective inhibition of cyclic AMP stimulated protein kinase.
    Sussman KE; Leitner JW; Rifkin RM
    Trans Assoc Am Physicians; 1978; 91():129-43. PubMed ID: 224550
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.